FDA Approves New Treatment for Aggressive Breast Cancer
Dr. Sylvia Adams, director of NYU Langone’s Breast Cancer Center, discusses the FDA’s approval of immunotherapy for triple-negative breast cancer.
FDA Approves TAVR for Low-Risk Heart Surgery Patients
Dr. Mathew R. Williams of NYU Langone’s Heart Valve Center discusses the expanded FDA approval of TAVR for low-risk heart surgery patients.
FDA Approves Treatment for a Common Type of Bladder Cancer
NYU Langone Health’s Dr. Arjun V. Balar and Dr. Gary D. Steinberg make breakthroughs with new treatments for bladder cancer.
FDA Clears NYU Langone Genome PACT
The FDA has cleared for use a gene sequencing test designed at NYU Langone Health and its Perlmutter Cancer Center to guide treatment decisions.
Federal Cancer Moonshot Program Aims to Jump-Start Screening
Dr. Benjamin G. Neel, director of NYU Langone’s Perlmutter Cancer Center, highlights the importance of cancer screening deferred by the pandemic.
Federal Grant Will Fund New Ambulances
A $2 million federal grant will help NYU Langone fund additional ambulances across Brooklyn and Staten Island.
fellow-request-support-letter-form.pdf
Date To , I am applying for the Lerner Holistic Integrative Health Nursing Fellowship at NYU Langone ...
Fellows Listing AY 25-26
Depart ment of Opht halmology Ophthalmology Fellows Except ional Training for Tomorrow's Leaders Heeyah ... Department of Ophthalmology
fellows.pdf
Current fellows Thomas Flagiello, MD (1-year clinical track) Placement of Previous Fellows Name Date ... Department of Neurology
Fewer Patients with COVID-19 Have Strokes Than First Thought
A study led by NYU Langone’s Dr. Shadi Yaghi shows that few patients with COVID-19 have strokes, but this rare complication can be more severe.